|

Modi-1 Moditope Clinical Trials

1 actively recruiting trial

Pipeline

Phase 1/2: 1

Top Sponsors

  • Scancell Ltd1

Indications

  • Squamous Cell Carcinoma of the Head and Neck1
  • High Grade Ovarian Serous Adenocarcinoma1
  • Renal Cell Cancer1
  • Triple Negative Breast Cancer1
  • Breast Cancer1

Other1 trial

Modi-1 Moditope in Breast, Head and Neck, Ovarian, or Renal Cancer
Phase 1/2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.